Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-008240
Filing Date
2024-07-22
Accepted
2024-07-22 11:36:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29884
2 filename2.txt TEXT-EXTRACT 4333
  Complete submission text file 0000000000-24-008240.txt   46184
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filed for) CIK: 0001867096 (see all company filings)

EIN.: 871082097 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 001-40880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)